A1LN34:BVMF
Alnylam Pharmaceuticals Inc Bdr
59,84 BRL
0,00%
(0,00) 1D
16-окт., 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1LN34...
Open
59,28 BRL
High
59,84 BRL
Low
59,28 BRL
Mkt. cap
31,02 млд
Avg. vol.
446,00
Volume
17,00
52-wk high
131,80 BRL
52-wk low
50,25 BRL
Shares outstanding
133,81 млн
No. of employees
2 миң
Open
59,28 BRL
High
59,84 BRL
Low
59,28 BRL
Mkt. cap
31,02 млд
Avg. vol.
446,00
Volume
17,00
52-wk high
131,80 BRL
52-wk low
50,25 BRL
Shares outstanding
133,81 млн
No. of employees
2 миң
News stories
From web sources and news partners
ad-hoc-news.de
·
54 мүнөт мурун
BofA cuts target to USD 336.00 for Alnylam Pharmaceuticals stock
ad-hoc-news.de
·
2 күн мурун
Citigroup cuts target to USD 320 for Alnylam Pharmaceuticals stock
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals Inc Bdr